GSM9742085: F, CAR-T-cells, HTO; Homo sapiens; OTHER
Cells were sorted for live, CD3+, and CAR+ cells from 13 patients at early (days 7-14), intermediate (days 25-35), and late (days 60-90 post-infusion) timepoints. Cells were hashed and batched to preserve identity and ensure similar frequencies of cells from both cilta- and ide-cel treated patients. Libaries construction for both scRNA and CITE followed manufacturer protocols (10X genomics).